Opioid-free Anesthesia With ESPB in VATS Operation
Comparison of ESPB With Opioid-free Anesthesia and Standardopioid Anesthesia in Patients Who Underwent Lobectomy With VATS Method: a Randomized Controlled Study.
1 other identifier
interventional
74
1 country
1
Brief Summary
Patients with an ASA score of 3 and below, who will undergo lobectomy with video-assisted thoracic surgery (VATS) method, and who gave informed consent will be included in this study. Patients with contraindications for the application of either of the two methods, with known chronic pain, opioid use, local anesthetic allergy, spinal deformity or mental or psychiatric problems that prevent cooperation, those taking anticoagulants, and those with infection at the injection site will not be included in the study. In addition, patients in the ESPB group who required intraoperative opioids, patients who failed ESPB, and patients who underwent open surgery in both groups will not be included in the analysis. Patients who agree to participate in the study will be randomly assigned to one of the study's opioid-free anesthesia and ESPB (erector spina plan block) (Group 1) or standard opioid (Group 2, control) anesthesia groups. Randomization will be at the ratio of 1:1 and will be done by the closed envelope method. Beforehand, a piece of paper with the name of one of the two groups will be placed inside the envelopes and the envelopes will be closed and mixed. A closed envelope will be drawn at random before the procedure for each patient, and procedures will be carried out according to the group specified on the paper.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 3, 2022
CompletedStudy Start
First participant enrolled
March 10, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 10, 2022
CompletedFirst Posted
Study publicly available on registry
April 11, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2022
CompletedMay 10, 2022
March 1, 2022
1 month
March 3, 2022
May 9, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Opioid consumption
measurement of postoperatif opioid requirement and consumption
the first 48 hours after surgery
Study Arms (2)
erector spinae plane block group
ACTIVE COMPARATORBefore this process, it will be produced from the bupivacaine plan, which will be made by entering unilaterally 3 cm lateral in the ultrasound to be made from a work section that will be made before the shipment and by lidocaine.
control group
ACTIVE COMPARATORgive opiod in this group of patients
Interventions
Local anesthetic injection to the erector spinae muscle plane at T5 level on the operation side.
Eligibility Criteria
You may qualify if:
- lobectomy with video-assisted thoracic surgery (VATS) method
- ASA score of 3 and below
- willing to be included
You may not qualify if:
- chronic pain
- current opioid use
- local anesthetic allergy
- spinal deformity or mental or psychiatric problems that prevent cooperation
- anticoagulant use
- infection at the injection site
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Marmara University
Istanbul, Maltepe, 34854, Turkey (Türkiye)
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
MELIHA ORHON ERGUN
Marmara University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- assistant professor
Study Record Dates
First Submitted
March 3, 2022
First Posted
April 11, 2022
Study Start
March 10, 2022
Primary Completion
April 10, 2022
Study Completion
May 1, 2022
Last Updated
May 10, 2022
Record last verified: 2022-03